In dermal MM portions, half of our tissues expressed ASIC2 strongly (50%), 45% expressed it weakly and only 5% showed no expression (Figure 4b,f and Figure 5d, Supplementary Figures S12–S15 second column, Figure S16). This evidence concerns the gene ASIC2 and Miyoshi myopathy.